Clinical Trial Update: To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update from AstraZeneca evaluating the hormonal response to hypoglycemia after a single oral dose of AZD1656 suspension in Type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED